Fibrosis and Scarring

Fibrosis is the excessive deposition of extracellular matrix — chiefly collagen — that replaces normal tissue when injury is severe or persistent. A scar is the end-product of this connective-tissue repair. While scarring restores structural continuity, extensive fibrosis distorts tissue architecture and impairs organ function, and it is a final common pathway of many chronic diseases.

Definition

Fibrosis is the pathologic accumulation of extracellular matrix, principally collagen, produced by activated fibroblasts and myofibroblasts in response to persistent or severe injury, resulting in scar formation and, when excessive, distortion of tissue architecture and loss of function.

Scope

The entry covers how fibrosis develops from sustained injury and inflammation, the central role of activated fibroblasts and myofibroblasts, the signalling that drives matrix deposition, and the difference between adaptive scarring and pathologic, progressive fibrosis. It treats fibrosis as a general-pathology mechanism, not as guidance on managing any fibrotic disease.

Core questions

• How does persistent injury and inflammation lead to fibrosis?
• What is the role of the myofibroblast in scar formation?
• When does adaptive scarring become pathologic, progressive fibrosis?

Key concepts

• Extracellular-matrix (collagen) deposition
• Fibroblast and myofibroblast activation
• Transforming growth factor-beta (TGF-β) signalling
• Adaptive scar versus progressive fibrosis
• Macrophage contribution to fibrosis
• Irreversible architectural distortion

Mechanisms

Fibrosis arises when injury and inflammation persist, sustaining signals — notably transforming growth factor-beta — that activate fibroblasts and recruit or differentiate myofibroblasts. These cells secrete large amounts of collagen and other matrix proteins and contract the wound, depositing the scar. Macrophages help drive the process, supplying mediators that promote fibroblast activation and matrix production. In a self-limited wound this leads to a stable scar, but when the injurious stimulus continues, matrix deposition outpaces degradation, the normal architecture is progressively replaced, and the process can become self-perpetuating fibrosis affecting organs such as the lung, liver, kidney, and heart (Wynn, 2012; Henderson, 2020; Friedman, 2013).

Clinical relevance

Fibrosis is the shared end-stage of many chronic conditions — including liver cirrhosis, idiopathic pulmonary fibrosis, and chronic kidney disease — and a major contributor to organ failure, which is why its mechanisms are an active focus of research. This entry explains those mechanisms for reference and does not provide diagnostic criteria or treatment recommendations.

Evidence & guidelines

The account rests on experimental and review literature on fibrosis mechanisms and on standard pathology references such as Robbins & Cotran Pathologic Basis of Disease (Kumar, Abbas, & Aster, 2021). As a basic mechanism, fibrosis is not itself governed by a single clinical guideline; management belongs to the specific fibrotic diseases.

History

Scar formation has been understood as the connective-tissue outcome of wound repair since classical pathology, but the modern concept of fibrosis as an active, driven process emerged with the identification of the myofibroblast and of profibrotic signalling such as TGF-β. Reviews over the past two decades have reframed fibrosis as a shared mechanism across organs and a target for therapy, distinguishing adaptive scarring from progressive, pathologic fibrosis (Wynn, 2012; Henderson, 2020).

Debates

Is established fibrosis reversible?

Whereas early fibrosis can regress when the injurious stimulus is removed, the extent to which advanced, cross-linked fibrosis can be reversed remains debated and is a central question for antifibrotic therapy.

Key figures

• Thomas A. Wynn
• Neil C. Henderson
• Scott L. Friedman

Seminal works

• wynn-2012
• henderson-2020
• friedman-2013

Frequently asked questions

What is the difference between a scar and fibrosis?

A scar is the localised connective-tissue patch that replaces injured tissue after a wound heals, whereas fibrosis refers more broadly to excessive matrix deposition — often within an organ and driven by persistent injury — that can distort architecture and impair function.

Which cell is mainly responsible for fibrosis?

The myofibroblast, an activated fibroblast that produces abundant collagen and contracts the tissue, is the principal effector cell of fibrosis, driven by signals such as transforming growth factor-beta.